Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) Peptid
Kurzübersicht für Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) Peptid (ABIN937992)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- ENGPVQALME VHEDFFLYKG GIYSHTPVSL GRPERYRRHG THSVKITGWG
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TINAGL1 antibody,
Alternative Names: TINAGL1 control peptide, TINAGL1 antibody Blocking Peptide, Anti-TINAGL1 Blocking Peptide, ARG1 Blocking Peptide, LCN7 Blocking Peptide, LIECG3 Blocking Peptide, TINAGRP Blocking Peptide, Tubulointerstitial Nephritis Antigen-Like 1 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
-
Hintergrund
- TINAGL1 may be implicated in the adrenocortical zonation and in mechanisms for repressing the CYP11B1 gene expression in adrenocortical cells. This is a non catalytic peptidase C1 family protein.
-
Molekulargewicht
- 52 kDa
Target
-